Startseite Lipid Peroxidation and Antioxidant Defenses in Cystic Fibrosis Patients
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Lipid Peroxidation and Antioxidant Defenses in Cystic Fibrosis Patients

  • Hassiba Benabdeslam , Hassane Abidi , Isabelle Garcia , Gabriel Bellon , Robert Gilly und André Revol
Veröffentlicht/Copyright: 1. Juni 2005
Veröffentlichen auch Sie bei De Gruyter Brill
Clinical Chemistry and Laboratory Medicine (CCLM)
Aus der Zeitschrift Band 37 Heft 5

Abstract

Lipid peroxidation biomarkers and antioxidant status were measured in 76 cystic fibrosis (CF) patients and compared to 40 control subjects. Univariate and multivariate statistics were performed in this study. Results showed that indicators of lipid peroxidation were higher in CF patients than in controls; thiobarbituric acid reactants and autoantibodies against oxidized low-density lipoproteins were significantly increased in CF patients. Red blood cells and whole blood glutathione peroxidase activities were lower in CF patients than in controls. No difference in red blood cell superoxide dismutase activity was observed. Measured concentration of glutathione peroxidase in plasma showed a higher mean value of this protein in CF patients than in controls. Retinol, α-tocopherol and β-carotene concentrations were all reduced in CF patients as compared to controls; this was particularly pronounced for β-carotene. The decreased α-tocopherol concentration was associated with higher percent hemolysis in CF patients. The results of this study indicate that both lipid peroxidation biomarkers and antioxidant status were disturbed in CF patients, despite medical assistance. Measures of oxidative stress parameters, such as thiobarbituric acid reactants, glutathione peroxidase, and β-carotene concentrations can be considered as significant indicators to discriminate CF patients and control subjects.

:
Published Online: 2005-06-01
Published in Print: 1999-05-01

Copyright (c)1999 by Walter de Gruyter GmbH & Co. KG

Artikel in diesem Heft

  1. Metrological Support of the Institute for Reference Materials and Measurements (IRMM) to Clinical Chemistry
  2. Web Applications for Total Quality Management
  3. Inflammation, the Acute Phase Response and Atherosclerosis
  4. Characterization of Two Distinct Mechanisms for Induction of Apoptosis in Human Vascular Endothelial Cells
  5. Lipid Peroxidation and Antioxidant Defenses in Cystic Fibrosis Patients
  6. Autoantibodies against Oxidised Low-Density Lipoprotein in Patients with Obstructive Sleep Apnoea
  7. Inter-α-Inhibitor (IαI) Concentration in Pig Plasma Is Independent of Acute-Phase Protein Response
  8. Advances in Reverse Transcription Polymerase Chain Reaction Analysis of Cellular mRNA Levels of Transforming Growth Factor-β1 by Capillary Electrophoresis with Laser-Induced Fluorescence Detection
  9. Determination of Ascorbic Acid in Plasma and Urine by High Performance Liquid Chromatography with Ultraviolet Detection
  10. A New Liquid Homogeneous Assay for the Determination of HDL-Cholesterol
  11. On the Standardization of Total Prostate-Specific Antigen: an Exercise with Two Reference Preparations
  12. Analytical Quality Specifications for Serum Lactate Dehydrogenase Isoenzyme 1 Based on Clinical Goals
  13. Physiological HEPES Buffer Proposed as a Calibrator for pH Measurement in Human Blood
  14. Towards Common Reference Intervals in Clinical Chemistry
  15. Evaluation of an Automated Method for Cytokine Measurement Using the Immulite® Immunoassay System
  16. Handbook of Interpretation of Diagnostic Tests by Jacques Wallach
  17. Assessment of a Major Academic Development Programme Linking European Union with Central and Eastern Europe
Heruntergeladen am 20.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/CCLM.1999.082/html
Button zum nach oben scrollen